Aspirin Dose Optimized in Non-Cardioembolic Ischemic Stroke "ADONIS"

Completed

Phase N/A Results

Summary of Purpose

To determine the optimal dose of acetylsalicylic acid (ASA) that would minimize both the recurrence of noncardioembolic ischemic stroke and the risk of drug-related adverse events.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 28 January 2010.

Unavailable Unavailable Unavailable Unavailable Unavailable Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Sponsors

  • United Laboratory & Philippine Council for Health Research and Development

Trial Design

Double-blind, randomized, multicenter study.

Contacts

Not available